We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
-16.56%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$35.3B
AUM Growth
-$2.37B
(-6.3%)
Cap. Flow
+$5.08B
Cap. Flow
% of AUM
14.42%
Top 10 Holdings %
Top 10 Hldgs %
12.79%
Holding
3,021
New
306
Increased
1,176
Reduced
1,104
Closed
398
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$410M |
| 2 |
Snap
SNAP
|
+$321M |
| 3 |
Altria Group
MO
|
+$312M |
| 4 |
Meta Platforms (Facebook)
META
|
+$295M |
| 5 |
Intel
INTC
|
+$283M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CERN
Cerner Corp
CERN
|
+$407M |
| 2 |
AbbVie
ABBV
|
+$283M |
| 3 |
S&P Global
SPGI
|
+$251M |
| 4 |
Amazon
AMZN
|
+$221M |
| 5 |
Eli Lilly
LLY
|
+$197M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.06% |
| 2 | Healthcare | 18.6% |
| 3 | Financials | 10.47% |
| 4 | Industrials | 10.2% |
| 5 | Consumer Discretionary | 7.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SLGC
2426
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $75K | ﹤0.01% |
+16,500
| New | +$98.2K |
|
2427
BARK
BARK
$77.3M
| $74K | ﹤0.01% |
+2,890
| New | +$146K |
|
2428
Flotek Industries
FTK
$875M
| $74K | ﹤0.01% |
12,372
-11,250
| -48% | -$84.9K |
|
|
LNAI
2429
Lunai Bioworks
LNAI
$10.2M
| $74K | ﹤0.01% |
+478
| New | +$219K |
|
|
NOVN
2430
DELISTED
Novan, Inc. Common Stock
NOVN
| $74K | ﹤0.01% |
31,800
-48,100
| -60% | -$133K |
|
|
AVDL
2431
DELISTED
Avadel Pharmaceuticals
AVDL
| $72K | ﹤0.01% |
+29,500
| New | +$121K |
|
2432
Cumberland Pharmaceuticals
CPIX
$103M
| $72K | ﹤0.01% |
34,592
-69,226
| -67% | -$160K |
|
2433
Regis Corp
RGS
$69M
| $72K | ﹤0.01% |
3,315
-525
| -14% | -$11.8K |
|
|
VLD
2434
DELISTED
Velo3D, Inc.
VLD
| $72K | ﹤0.01% |
1,500
+1,149
| +327% | +$134K |
|
2435
Hydrofarm Holdings
HYFM
$3.24M
| $71K | ﹤0.01% |
+2,040
| New | +$166K |
|
2436
Innodata
INOD
$1.94B
| $71K | ﹤0.01% |
14,600
+3,300
| +29% | +$21.3K |
|
2437
Dominari Holdings
DOMH
$57.2M
| $70K | ﹤0.01% |
11,876
-2,712
| -19% | -$15.6K |
|
|
INFN
2438
DELISTED
Infinera Corporation Common Stock
INFN
| $70K | ﹤0.01% |
+13,000
| New | +$83.2K |
|
|
ML
2439
DELISTED
MoneyLion Inc.
ML
| $70K | ﹤0.01% |
1,773
| – | – |
|
2440
Bioventus
BVS
$837M
| $69K | ﹤0.01% |
10,132
-700
| -6% | -$7.14K |
|
|
DCOY
2441
Decoy Therapeutics
DCOY
$2.09M
| $69K | ﹤0.01% |
9
-1
| -10% | -$8.63K |
|
|
XNET
2442
Xunlei
XNET
$367M
| $69K | ﹤0.01% |
43,600
-300
| -0.7% | -$426 |
|
|
KG
2443
Kestrel Group
KG
$70.3M
| $68K | ﹤0.01% |
1,742
-555
| -24% | -$24.8K |
|
2444
Lightwave Logic
LWLG
$924M
| $67K | ﹤0.01% |
+10,200
| New | +$88.6K |
|
|
CYT
2445
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
| $67K | ﹤0.01% |
+22,400
| New | +$57.2K |
|
|
MDRR
2446
Medalist Diversified Inc
MDRR
$18.4M
| $66K | ﹤0.01% |
4,956
-2,855
| -37% | -$45.3K |
|
|
GRTX
2447
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
| $66K | ﹤0.01% |
50,900
-99,200
| -66% | -$170K |
|
2448
Precision BioSciences
DTIL
$188M
| $65K | ﹤0.01% |
1,353
-1,324
| -49% | -$77.7K |
|
|
OIIM
2449
DELISTED
02Micro International
OIIM
| $65K | ﹤0.01% |
17,600
-19,200
| -52% | -$70.1K |
|
|
SKE
2450
Skeena Resources
SKE
$3.38B
| $64K | ﹤0.01% |
12,025
-8,600
| -42% | -$72K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q2 2022 Portfolio in Review
As of Q2 2022, Two Sigma Advisers held 3,021 positions worth $35.3B, down 6.3% from $37.6B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Two Sigma Advisers deployed $5.08B of net new capital in Q2 2022, opening 306 new positions and adding to 1,176 existing holdings. Its largest new stake was Snap: 14,064,077 shares worth $185M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was AbbVie, an estimated $283M trimmed.
- Two Sigma Advisers's largest Q2 2022 buy was Snap: 14,064,077 shares worth $185M.
- Two Sigma Advisers added most to Netflix in Q2 2022, an estimated $410M increase.
- Two Sigma Advisers's biggest Q2 2022 reduction was AbbVie, cutting an estimated $283M.
- Two Sigma Advisers fully exited Cerner Corp in Q2 2022, selling an estimated $407M.
- Two Sigma Advisers's ten largest holdings make up 13% of its $35.3B portfolio in Q2 2022.
- Two Sigma Advisers opened 306 new positions and closed 398 in Q2 2022.
- Two Sigma Advisers's portfolio value fell 6.3% quarter-over-quarter to $35.3B.
Based on Two Sigma Advisers's 13F filing for Q2 2022, filed 15 Aug 2022.